Spotlight
Clinical
Events
CME
Partners
Subscribe
- COVID-19
- Biosimilars
- Cataract Therapeutics
- DME
- Gene Therapy
- Workplace
- Ptosis
- Optic Relief
- Imaging
- Geographic Atrophy
- AMD
- Presbyopia
- Ocular Surface Disease
- Practice Management
- Pediatrics
- Surgery
- Therapeutics
- Optometry
- Retina
- Cataract
- Pharmacy
- IOL
- Dry Eye
- Understanding Antibiotic Resistance
- Refractive
- Cornea
- Glaucoma
- OCT
- Ocular Allergy
- Clinical Diagnosis
- Technology
Poll results: Do you believe biosimilars have the same efficacy as branded medications?
Results from our recent poll indicate a mixed bag of responses from ophthalmologists.
Ophthalmology Times® polled our audience with the following question from December 3, 2022 to December 16, 2022: Do you believe biosimilars have the same efficacy as branded medications?
The poll appeared on OphthalmologyTimes.com and was promoted in our e-newsletters during this time. Results show a mixed bag of responses.
58 responses were recorded, in total. Of these:
43% responded, "Yes."
28% responded, "No."
29% responded, "Unsure."
.
Related Videos
Related Content
